All lobbying filings

TIBER CREEK GROUP

Lobbying for VERTEX PHARMACEUTICALS · Global biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 19, 2026

Official filing document

Bills named in this filing 3

HR 1227
Alternatives to PAIN Act
S 475
Alternatives to PAIN Act
HR 1518
New Era of Preventing End-Stage Kidney Disease Act

Lobbying activity 2

Health Issues

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

Defense

Issues related to coverage of opioid alternatives.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.